VITASPRING BIOMEDICAL CO., LTD. (VSBC) Return on equity 2017–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
57.7%FY2022 · since FY2017: -1.5% → 57.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 57.7% | -383.8 pp |
| FY2021 | 441.4% | — |
| FY2017 | -1.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →